Fibrin Sealants Market Segmentation:
Application Segment Analysis
Cardiovascular Surgery is anticipated to grow at the quickest rate over the forecast period. Cardiovascular surgery, also referred to as heart surgery, is a type of surgery that involves operating on the heart to treat serious health issues. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) account for 17.9 million deaths per year, or 32% of all fatalities worldwide, making them the leading cause of death globally. Fibrin sealants are used in cardiovascular surgery to reduce the need for blood and blood product transfusions, improve hemostasis in heparin-treated patients, and control problematic bleeding on vascular anastomoses through tissue sealing. According to estimates, the market for cardiovascular procedures will grow as the number of cardiovascular illnesses rises. One in four fatalities in the United States occurs as a result of heart disease, according to the Centers for Disease Control and Prevention (CDC), which is what is causing the segment to rise.
Type Segment Analysis
The global fibrin sealant market is segmented and analyzed by type into liquid, patch, and power. Out of the three types, the liquid segment is estimated to gain the largest market share over the projected time frame. This can be attributed to the better procedural results than the patch, and powder type. Furthermore, the quick action and higher rational stability of liquid solutions are expected to propel this market even further. Moreover, the fact that the fibrin sealant patch can achieve hemostasis 3–4 minutes after the application is one of its key benefits. Therefore, it is anticipated to boost the segment’s growth in the region.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Application |
|
|
By Technology |
|
|
By End-User |
|
